GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wonbiogen Co Ltd (XKRX:307280) » Definitions » Deferred Tax

Wonbiogen Co (XKRX:307280) Deferred Tax : ₩1,313 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wonbiogen Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Wonbiogen Co's change in deferred tax for the three months ended in Sep. 2024 was ₩369 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was ₩1,313 Mil.

Wonbiogen Co Deferred Tax Historical Data

The historical data trend for Wonbiogen Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wonbiogen Co Deferred Tax Chart

Wonbiogen Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial 10.49 380.31 -135.74 394.35 1,195.89

Wonbiogen Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 138.50 286.35 245.11 412.79 369.02

Wonbiogen Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,313 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wonbiogen Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Wonbiogen Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Wonbiogen Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wonbiogen Co Ltd (XKRX:307280) » Definitions » Deferred Tax
Comparable Companies
XKRX:450330 XKRX:246720 XKRX:059210 XKRX:261200 XKRX:049180 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST XSWX:STMN XPAR:DIM COO TSE:7733 HOLX ALGN
Traded in Other Exchanges
N/A
Address
56, 1 Gongdan-ro 5-gil, Gyeongsangbuk-do, Gumi-si, KOR
Website
http://www.wonbiogen.co.kr
Wonbiogen Co Ltd is engaged in the manufacturing of medical supplies and instruments. Its product portfolio comprises Therasorb Algi Adhesive, Therasorb AD, Renoderm, Remscar Gel, Meditouch Liquid, and Meditouch Bend, among others.

Wonbiogen Co Headlines

No Headlines